Houston, TX, United States of America

Andrew Sikora

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andrew Sikora

Introduction

Andrew Sikora is a notable inventor based in Houston, TX, who has made significant contributions to the field of biomedical engineering. With a total of 3 patents, his work focuses on developing advanced materials and methods for cancer treatment. His innovative approach combines synthetic biology with immunotherapy, aiming to improve patient outcomes in oncology.

Latest Patents

One of Andrew Sikora's latest patents is titled "Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase." This patent describes compositions comprising multi-domain peptide (MDP) hydrogels, which include peptides with at least one N6-(1-iminoethyl)-lysine side chain. These hydrogels can also incorporate a STING agonist, an immune checkpoint inhibitor, and/or an anti-cancer therapy, providing a multifaceted approach to cancer treatment.

Another significant patent is related to "Materials and methods relating to immunogenic epitopes from human papillomavirus." This patent focuses on head and neck squamous cell carcinomas (HNSCCs) associated with human papillomavirus subtype 16 (HPV16) infections. It presents novel immunogenic epitopes from HPV16 E2, E6, and E7 antigens, which are restricted by common human leukocyte antigen (HLA) alleles. These epitopes can be utilized in conjunction with checkpoint blockade for targeted immunotherapy.

Career Highlights

Andrew Sikora has worked with prestigious institutions such as Baylor College of Medicine and Rice University. His research has significantly advanced the understanding of cancer biology and therapeutic strategies, making him a valuable contributor to the scientific community.

Collaborations

Throughout his career, Andrew has collaborated with esteemed colleagues, including Jeffrey Dale Hartgerink and David Leach. These partnerships have fostered innovative research and development in the field of cancer treatment.

Conclusion

Andrew Sikora's contributions to biomedical engineering and cancer research exemplify the impact of innovative thinking in addressing complex medical challenges. His patents and collaborations highlight the importance of interdisciplinary approaches in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…